Shandong Intco Medical Products Co Ltd Net Asset Quality Index
Shandong Intco Medical Products Co Ltd net asset quality index. Shandong Intco Medical Products Co Ltd (300677) has a Net Asset Quality Index of 47.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥41.24 Billion minus total liabilities of CN¥21.86 Billion yields net assets of CN¥19.39 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Shandong Intco Medical Products Co Ltd (300677) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Shandong Intco Medical Products Co Ltd (2013–2025)
Net asset quality index of Shandong Intco Medical Products Co Ltd from 2013 to 2025. This chart shows how Shandong Intco Medical Products Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at 47.0%, representing net assets of CN¥19.39 Billion against total assets of CN¥41.24 Billion CNY. See Shandong Intco Medical Products Co Ltd net assets for net asset value and shareholders' equity analysis.
Shandong Intco Medical Products Co Ltd Net Asset Quality Index by Year (2013–2025)
Shandong Intco Medical Products Co Ltd net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Shandong Intco Medical Products Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shandong Intco Medical Products Co Ltd market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 46.3% | CN¥18.57 Billion | CN¥40.09 Billion | CN¥21.52 Billion | ▼ -4.7 pp |
| 2024 | 51.1% | CN¥17.68 Billion | CN¥34.63 Billion | CN¥16.95 Billion | ▼ -9.1 pp |
| 2023 | 60.2% | CN¥16.29 Billion | CN¥27.08 Billion | CN¥10.78 Billion | ▼ -14.5 pp |
| 2022 | 74.7% | CN¥16.05 Billion | CN¥21.48 Billion | CN¥5.43 Billion | ▼ -3.5 pp |
| 2021 | 78.2% | CN¥16.12 Billion | CN¥20.62 Billion | CN¥4.50 Billion | ▲ +5.2 pp |
| 2020 | 73.0% | CN¥9.44 Billion | CN¥12.93 Billion | CN¥3.49 Billion | ▲ +22.8 pp |
| 2019 | 50.2% | CN¥1.50 Billion | CN¥2.99 Billion | CN¥1.49 Billion | ▼ -2.3 pp |
| 2018 | 52.5% | CN¥1.27 Billion | CN¥2.42 Billion | CN¥1.15 Billion | ▼ -13.1 pp |
| 2017 | 65.6% | CN¥1.09 Billion | CN¥1.66 Billion | CN¥570.73 Million | ▲ +19.6 pp |
| 2016 | 46.0% | CN¥535.45 Million | CN¥1.16 Billion | CN¥628.30 Million | ▼ -9.0 pp |
| 2015 | 55.1% | CN¥415.19 Million | CN¥754.13 Million | CN¥338.94 Million | ▲ +29.4 pp |
| 2014 | 25.6% | CN¥168.38 Million | CN¥656.54 Million | CN¥488.16 Million | ▲ +4.7 pp |
| 2013 | 21.0% | CN¥147.82 Million | CN¥704.49 Million | CN¥556.67 Million | — |